BACKGROUND AND PURPOSE: High-resolution vessel wall MR imaging is prone to slow-flow artifacts, particularly when gadolinium shortens the T1 relaxation time of blood. This study aimed to determine the optimal preparation pulses for contrast-enhanced high-resolution vessel wall MR imaging. MATERIALS AND METHODS: Fifty patients who underwent both motion-sensitized driven equilibrium and delay alternating with nutation for tailored excitation (DANTE) preparation pulses with contrast-enhanced 3D-T1-FSE were retrospectively included. Qualitative analysis was performed using a 4-grade visual scoring system for black-blood performance in the small-sized intracranial vessels, overall image quality, severity of artifacts, and the degree of blood suppression in all cortical veins as well as transverse sinuses. Quantitative analysis of the M1 segment of the MCA was also performed. RESULTS: The qualitative analysis revealed that motion-sensitized driven equilibrium demonstrated a significantly higher black-blood score than DANTE in contrast-enhanced 3D-T1-FSE of the A3 segment (3.90 versus 3.58, P < .001); M3 (3.72 versus 3.26, P = .004); P2 to P3 (3.86 versus 3.64, P = .017); the internal cerebral vein (3.72 versus 2.32, P < .001); and overall cortical veins (3.30 versus 2.74, P < .001); and transverse sinuses (2.82 versus 2.38, P < .001). SNRlumen, contrast-to noise ratiowall-lumen, and SNRwall in the M1 vessel were not significantly different between the 2 preparation pulses (all, P > .05). CONCLUSIONS: Motion-sensitized driven equilibrium demonstrated improved blood suppression on contrast-enhanced 3D-T1-FSE in the small intracranial arteries and veins compared with DANTE. Motion-sensitized driven equilibrium is a useful preparation pulse for high-resolution vessel wall MR imaging to decrease venous contamination and suppress slow-flow artifacts when using contrast enhancement.
Background/Objectives: From the viewpoint of personalized medicine, it is important to properly select patients with a complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) because they are candidates for “watch-and-wait” management in locally advanced rectal cancer (LARC). The aims of this study were to evaluate the added value of diffusion-weighted imaging (DWI) b2000 to high-resolution T2-weighted images (HR-T2WI) and to compare the diagnostic performance of DWI b2000 and b1000 for assessing a CR in patients with LARC after nCRT. Methods: This retrospective study included 55 patients (male: 40, female: 15; mean age: 60.1) who underwent pre- and post-nCRT 3T MRI, including DWIb1000 and DWIb2000. Two blinded radiologists independently assessed the likelihood of a CR using a five-point scale across three image sets: T2-weighted images (T2WI), T2WI + DWIb1000, and T2WI + DWIb2000. T2WI were provided because DWI is not used as a standalone sequence in clinical practice when evaluating the therapeutic response to nCRT. A crossover review of DWIb1000 and DWIb2000 with a four-week interval was used to minimize recall bias. The reference standard of a CR was histopathologic examination or clinical remission in cases of watch-and-wait management. For each reader, diagnostic performance was compared across three image sets using pairwise comparisons of the receiver operating characteristic (ROC) curves. Results: The study population comprised 19 patients with a CR and 36 patients with residual tumor. For both readers, adding DWIb2000 significantly enhanced diagnostic performance compared to T2WI alone (AUC for reader 1: 0.918, 0.806, p = 0.0288; AUC for reader 2: 0.868, 0.768, p = 0.0414, respectively), likewise, DWIb1000 (for reader 1: 0.955, p = 0.0015; for reader 2: 0.863, p = 0.0162). However, no significant difference in diagnostic performance was found between DWIb1000 and DWIb2000 for each reader (for reader 1: p = 0.0931; for reader 2: p = 0.8936). Conclusions: Adding DWIb2000 to T2WI improved diagnostic performance for identifying a CR after nCRT compared to T2WI alone. No statistical difference was detected between DWIb1000 and DWIb2000.